Having trouble accessing articles? Reset your cache.

Lipoxen, Baxter deal

Lipoxen will receive a $2 million license fee from Baxter under a 2005 deal

Read the full 141 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE